MBXMBX Biosciences, Inc.

$66.87

Who owns MBX

157 institutions reported holding MBX for 2026Q1, together 113% of the company, more than the 137 a quarter earlier.

157

Institutions reporting a position · as of 2026Q1 · up from 137 the quarter before

Shares held by institutions
52.5M

Shares held by institutions · 113% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.57B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
33 / 19

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
7
New positions
33
Positions exited
19
Added to
43
Reduced
46
Institutional ownership by quarter, 2024Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q115752.5M$1.57B
2025Q413748.4M$1.53B
2025Q311747.8M$836M
2025Q28836.8M$420M
2025Q17935.7M$263M
2024Q46332.9M$606M
2024Q34430.3M$784M
Largest reported holders, 2026Q1
HolderShares% of companyValue
Frazier Life Sciences Management, L.P.6.7Mn/a$199M
ORBIMED ADVISORS LLC3.6Mn/a$109M
NEA Management Company, LLC3.6Mn/a$108M
WELLINGTON MANAGEMENT GROUP LLP3.2Mn/a$95M
BlackRock Inc.2.9Mn/a$88M
FMR LLC2.9Mn/a$88M
Deep Track Capital, LP2.8Mn/a$82M
NVP ASSOCIATES, LLC2.1Mn/a$64M
VANGUARD GROUP INC2.0Mn/a$59M
Polar Capital Holdings Plc1.6Mn/a$48M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…